Intellectual Property Cases filed in the Third Circuit Courts
Cases 21 - 30 of 160
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00632
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00752
Plaintiff: Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., et al.
as 1:2019cv00315
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2019cv08233
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant: MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2019cv05802
Plaintiff: CELGENE CORPORATION
Defendant: MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL.
as 2:2017cv11635
Petitioner: BAKER BOTTS LLP and PHV STEPHEN M. HASH
Defendant: LUPIN LTD, MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED and others
Plaintiff: HORIZON PHARMA, INC and POZEN INC.
Cause Of Action: Motion to Quash
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01699
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2018cv01562
Plaintiff: AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Defendant: Mylan Inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2018cv16035
Plaintiff: CELGENE CORPORATION
Defendant: MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al We have downloadable decisions or orders for this case
as 3:2018cv14305
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant: MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?